Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/30/1990 | US4966895 Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents |
10/30/1990 | US4966894 Polysulfated heparins for treating diseases caused by retroviruses |
10/30/1990 | US4966893 Method for treatment of senile dementia |
10/30/1990 | US4966892 Processes for preparation of aloe products products produced thereby and compositions thereof |
10/30/1990 | US4966891 Fluorocytidine derivatives |
10/30/1990 | US4966890 Method and composition for arresting angiogenesis and capillary, cell or membrane leakage |
10/30/1990 | US4966776 Administering a daily dosage of composition comprising potassium citrate |
10/30/1990 | US4966773 Useful for treating dry eye syntrom, conjunctivitis |
10/30/1990 | US4966772 DHP delayed release preparation |
10/30/1990 | US4966770 Prednisone microencapsulated granules |
10/30/1990 | US4966769 Method for delivering dosage form for diltiazem |
10/30/1990 | US4966768 Sustained release etodolac |
10/30/1990 | US4966734 Deodorization of fatty ester mixtures |
10/30/1990 | US4966732 Process for the production of 1,2-dithiolan-3-pentanoic acid (thioctic acid) and 8-hydrocarbylthio-6-oxooctanoic acid |
10/30/1990 | CA1275652C2 Aminomethyl oxooxazolidinyl benzene derivatives useful as antibacterial agents |
10/30/1990 | CA1275627C Composition for oral hygiene |
10/29/1990 | WO1990013542A1 Anti-hiv drug |
10/29/1990 | WO1990013293A1 Cytochalasin compositions and therapeutic methods |
10/29/1990 | WO1990013291A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
10/29/1990 | CA2443232A1 Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
10/29/1990 | CA2053926A1 Anti-hiv agent |
10/29/1990 | CA2050936A1 Beta-hydroxamate d-aspartic acid for treatment of viral infections and tumours |
10/29/1990 | CA2031520A1 Cytochalasin compositions and therapeutic methods |
10/29/1990 | CA2015657A1 Pharmaceutical composition |
10/29/1990 | CA2015580A1 Process for the preparation of penem compounds |
10/28/1990 | WO1990012800A1 Phospholipid derivatives |
10/28/1990 | WO1990012795A1 Substituted 3-amino chromans |
10/28/1990 | CA2015678A1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists |
10/28/1990 | CA2015669A1 4-phenylmethyl ih-indole derivatives, intermediates and process for their preparation, use as medicaments and compositions containing them |
10/28/1990 | CA2015665A1 Hydroxyphenethylamine derivative and its salts, process for their preparation, use as medicaments and as specific pharmacological implement |
10/28/1990 | CA2015649A1 Pharmaceutical composition for preventing and treating thrombosis |
10/28/1990 | CA2015626A1 Benzothiazolinonic derivatives, process for their preparation and pharmaceutical compositions containing the same |
10/28/1990 | CA2015579A1 Tetrahydroisoquino (2,1-c) (1,3) benzodiazepines, a process for their preparation and their use as medicaments |
10/28/1990 | CA2015360A1 1-azabicyclo¬3.2.0|hept-2-ene-2-carboxylic acid compounds |
10/28/1990 | CA2002137A1 Anti-human immunodeficiency virus composition |
10/27/1990 | CA2015569A1 Chemical compounds |
10/27/1990 | CA2012727A1 Process and an apparatus for the preparation of sterile injectable powders of antibiotics |
10/26/1990 | CA2015427A1 Pharmaceutical composition for topical ophthalmic use having improved local tolerability |
10/26/1990 | CA2015398A1 Rhodomycin derivatives with cytostatic activity |
10/26/1990 | CA2015395A1 Rhodomycin derivatives with cytostatic activity |
10/26/1990 | CA2014760A1 Chemical compounds |
10/26/1990 | CA2014537A1 4-imidazoline derivatives |
10/26/1990 | CA2010886A1 Cell growth inhibitory macrocyclic lactones denominated combretastatin d-1 and combretastatin d-2 |
10/25/1990 | WO1990012786A1 3-halogeno-2,3-diphenylacrylaldehyde derivative, method of production thereof and curing agent for hyperlipidemia |
10/25/1990 | DE3913120A1 Solid compsns. contg. active agent for skin - comprising active material, e.g. cosmetic pigment or physiological agent, and water soluble binder contg. wax, fat or oil like substance |
10/25/1990 | CA2032489A1 3-halogeno-2,3-diphenylacrylaldehyde derivatives, process for preparing the same and a pharmaceutical composition for treating hyperlipidemia |
10/25/1990 | CA2015312A1 Control of protozoal disease |
10/25/1990 | CA2015283A1 Cephalosporin compounds and their use |
10/25/1990 | CA2015173A1 Diazine derivatives, a process for their preparation and medicaments containing these compounds |
10/24/1990 | EP0394135A1 Macrolide derivates, process for their preparation and pharmaceutical compositions containing them |
10/24/1990 | EP0394122A2 Use of tetracyclines to manufacture a medicament for the treatment and prevention of AIDS |
10/24/1990 | EP0394120A1 Substituted azetidinyl isothiazolo-pyrydone derivatives, their preparation and their use as medicines |
10/24/1990 | EP0394118A1 2,6-Aminoheptanedioic acid unsaturated derivatives, process for their preparation and their use as medicaments |
10/24/1990 | EP0394112A2 Use of dipyrido(4,3-b)(3,4-f) indoles for the preparation of medicaments for the treatment of AIDS |
10/24/1990 | EP0394101A1 Benzothiazepine derivatives, process for their preparation and thereby obtained intermediates, their use as medicines and compositions containing them |
10/24/1990 | EP0394045A2 Cyclophosphamide lyophilizates |
10/24/1990 | EP0394039A1 A method for preparing 4-Alkoxyalkyl-4-aminophenylpiperidines and derivatives thereof |
10/24/1990 | EP0394026A1 Formulation containing an imidazo[4,5-c]quinolin derivative |
10/24/1990 | EP0394022A1 Calcium pantothenate composit |
10/24/1990 | EP0393973A1 Antitumor Agent Indicated for lung cancer |
10/24/1990 | EP0393936A1 3-substituted-2-oxindole derivatives as antiinflammatory agents |
10/24/1990 | EP0393926A1 1-Aminoisoquinoline derivatives |
10/24/1990 | EP0393923A1 6-Fluoroshikimic acid derivatives |
10/24/1990 | EP0393920A2 Antiviral nucleoside derivatives |
10/24/1990 | EP0393909A1 Composition |
10/24/1990 | EP0393904A2 Moisturising vehicle for topical application of vitamin a acid |
10/24/1990 | EP0393890A1 Injectable compositions containing 25-cyclohexyl-avermectin B1 |
10/24/1990 | EP0393786A1 New retro-inverse, one- or more bond bearing analogues of thymopentin, a method for synthesizing the same and their employment for the preparation of pharmaceutical |
10/24/1990 | EP0393782A2 Catecholamine esters |
10/24/1990 | EP0393766A2 New 3-N substituted carbamoyl-indole derivatives |
10/24/1990 | EP0393747A2 Mebeverine dosage form |
10/24/1990 | EP0393738A1 Hydroxyalkylfuranyl derivatives |
10/24/1990 | EP0393727A2 Transdermal delivery system |
10/24/1990 | EP0393696A2 7-(Substituted)amino)-8-(substituted)Carbonyl)-methylamino-1-oxaspiro (4,5)decanes as diuretics antiinflammatory, and cerebrovascular agents |
10/24/1990 | EP0393658A2 Novel steroid derivatives |
10/24/1990 | EP0393607A2 Phenylcarboxylic acid derivatives having a hetero ring |
10/24/1990 | EP0393575A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent |
10/24/1990 | EP0393574A2 Hexitol derivatives |
10/24/1990 | EP0393572A2 Controlled release tablets containing flavoxate |
10/24/1990 | EP0393539A2 Oral preparation containing estradiol valerate |
10/24/1990 | EP0393537A2 Granulation product of calcium ascorbate |
10/24/1990 | EP0393534A2 Pharmaceutically active pteridine derivatives |
10/24/1990 | EP0393530A1 5,11-dihydro-6H-pyrido[2,3,-b][1,4]benzodiazepin-6-ones and -thiones and their use in the prevention or treatment of AIDS |
10/24/1990 | EP0393529A1 5,11-dihydro-6H-dipyrido [3,2-b:2',3'-e][1,4]diazepin-6-ones and their use in the prevention or treatment of AIDS |
10/24/1990 | EP0393500A1 Arylpyridazines, their preparation, their use and pharmaceuticals containing them |
10/24/1990 | EP0393494A2 Bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
10/24/1990 | EP0393493A2 Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
10/24/1990 | EP0393457A1 Proteinase inhibitor |
10/24/1990 | EP0393441A1 Mercapto-acylamino acids |
10/24/1990 | EP0393371A1 A ringworm vaccine |
10/24/1990 | EP0393256A1 Aminoalkyl naphthalenediols as host resistance enhancers against viral infection |
10/24/1990 | EP0393190A1 Copolymers of vinyl alcohol with vinyl acetate, cross-linked by glutaric dialdehyde, method of obtaining them and a phramaceutical preparation based thereon |
10/24/1990 | EP0393150A1 Zinc ceftiofur complexes |
10/24/1990 | EP0393074A1 New pyrrolidines |
10/24/1990 | EP0368972A4 Method of safely providing anesthesia or conscious sedation |
10/24/1990 | EP0280992B1 Cyclohexene carboxylic-acid esters, process for their preparation and their use |
10/24/1990 | CN1046334A 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl adenosine derivatives |
10/24/1990 | CN1046333A Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing methyle-trithio group, and targeted forms thereof |
10/24/1990 | CN1046330A Tetrahydrobenz (c,d) indole serotonin agonists |
10/24/1990 | CN1046282A Antiparasitic formulations |